enGene Holdings Q3 GAAP EPS Misses Estimates

Seeking Alpha··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

enGene Holdings reported a third-quarter GAAP loss of $0.47 per share, missing analyst expectations by $0.04. As of July 31, 2026, the company held $266.3 million in cash, cash equivalents, and marketable securities, providing significant operational flexibility.

Impact on assets 1

Biotech & Genomic Medicine▼